250 related articles for article (PubMed ID: 21753077)
1. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
[TBL] [Abstract][Full Text] [Related]
2. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
4. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
5. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
7. 14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.
Bukhari IA; Gauthier KM; Jagadeesh SG; Sangras B; Falck JR; Campbell WB
J Pharmacol Exp Ther; 2011 Jan; 336(1):47-55. PubMed ID: 20881018
[TBL] [Abstract][Full Text] [Related]
8. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.
Hercule HC; Schunck WH; Gross V; Seringer J; Leung FP; Weldon SM; da Costa Goncalves ACh; Huang Y; Luft FC; Gollasch M
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):54-60. PubMed ID: 18927469
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
10. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy.
Romashko M; Schragenheim J; Abraham NG; McClung JA
Trends Pharmacol Sci; 2016 Nov; 37(11):945-962. PubMed ID: 27633970
[TBL] [Abstract][Full Text] [Related]
12. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
[TBL] [Abstract][Full Text] [Related]
13. 11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.
Bukhari IA; Shah AJ; Gauthier KM; Walsh KA; Koduru SR; Imig JD; Falck JR; Campbell WB
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1574-83. PubMed ID: 22307677
[TBL] [Abstract][Full Text] [Related]
14. 20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site.
Chen Y; Falck JR; Tuniki VR; Campbell WB
J Pharmacol Exp Ther; 2009 Dec; 331(3):1137-45. PubMed ID: 19762546
[TBL] [Abstract][Full Text] [Related]
15. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
16. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
[TBL] [Abstract][Full Text] [Related]
17. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Zhao X; Yamamoto T; Newman JW; Kim IH; Watanabe T; Hammock BD; Stewart J; Pollock JS; Pollock DM; Imig JD
J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364
[TBL] [Abstract][Full Text] [Related]
20. 11,12-Epoxyeicosatrienoic acid induces vasodilator response in the rat perfused mesenteric vasculature.
Bihzad SM; Yousif MH
Auton Autacoid Pharmacol; 2017 Jan; 37(1):3-12. PubMed ID: 28332266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
